In recent years, the prognostic and predictive role of the nucleoside transporter hENT-1 has emerged in different cancer types and clinical settings [4,5,13,14,15,16,17]; nevertheless, the molecular mechanisms regulating its expression in cancer patients have been less investigated. Here, SLC29A1 is linked to cancer.